@bubu12
 

bubu12 : https://www.nature.com/articles/s41586-020-2639-4 voila pour Pfizer.

Author notes

These authors contributed equally : Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin

Affiliations

Vaccine Research and Development, Pfizer Inc, Hurley, UK

Nicholas Kitchin, Stephen Lockhart & Ruth Bailey

 Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA

Judith Absalon, Alejandra Gurtman, Kena A. Swanson, Kenneth Koury, Warren Kalina, David Cooper, Kristin R. Tompkins, Philip R. Dormitzer, William C. Gruber & Kathrin U. Jansen

 Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA

Ping Li

 BioNTech, Mainz, Germany

Özlem Türeci & Uğur Şahin

 Ethics declarations

Competing interests

N.K., J.A., A.G., S.L., R.B., K.A.S., P.L., K.K., W.K., D.C., K.R.T., P.R.D., W.C.G. and K.U.J. are employees of Pfizer and may hold stock options. U.Ş. and Ö.T. are stock owners, management board members and employees at BioNTech and are inventors on patents and patent applications related to RNA technology. M.J.M., K.E.L., K.N., E.E.W., A.R.F., R.F. and V.R. received compensation from Pfizer for their role as study investigators. C.F.-G. and P.-Y.S. received compensation from Pfizer to perform the neutralization assay.

bubu12 vous remercie de lire ce PubliReportage Pfizer ®